Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on July 22, 2025
Spectrum Spine Inc Clears US FDA with Family of Lumbar Interbody Cages with BioBraille
EIN Presswire
·
July 22, 2025
Spectrum's Lumbar Cage family with multiple surgical solutions will feature BioBraille, its proprietary, disruptive surface technology. INLET BEACH, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Spectrum Spine Inc is pleased to announce U.S. …
Margarita Monday: Sip, Snack & Speak Up for Kids in Foster Care
EIN Presswire
·
July 22, 2025
A Flavorful Fiesta with Purpose — Part of Boca Chamber’s Boca Festival Days BOCA RATON, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Speak Up for Kids Palm Beach County, a nonprofit committed to advocating for the most vulnerable children in …
DYN’R US and Cablon Medical B.V. to Bring CNERGY Go! Patient Identity and Accessory Verification Solution to the U.S.
EIN Presswire
·
July 22, 2025
DYN’R US partners with Cablon Medical to launch CNERGY Go!, a biometric solution enhancing patient safety in U.S. radiation oncology clinics. MIAMI, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- DYN’R US Inc., a specialized provider of …
CTRL+ALT Digital Wins Excellence Award For Fifth Consecutive Year
EIN Presswire
·
July 22, 2025
JACKSONVILLE, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- CTRL+ALT Digital, a leading force in digital marketing and web development, proudly announces its recognition as a recipient of the prestigious National Excellence Award by UpCity. This …
XORTX Completes Non-Brokered Private Placement of Units
GlobeNewswire
·
July 22, 2025
Not For Distribution to United States News Wire Services or for Dissemination in the United States CALGARY, Alberta, July 22, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late- …
Advanced Hair Restoration Technology Arrives in Surfside, FL as SJI Dermatology Partners with GetHairMD
EIN Presswire
·
July 22, 2025
Board-certified dermatologist brings comprehensive multi-modal treatments to South Florida patients SURFSIDE, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- SJI Dermatology announces a strategic partnership with GetHairMD, bringing a suite of …
Pennant Announces Second Quarter 2025 Earnings Release and Call
GlobeNewswire
·
July 22, 2025
EAGLE, Idaho, July 22, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter …
First-of-Its-Kind Study Confirms AI Tools Cut Psychotherapist Admin Time and Boost Treatment Effectiveness
EIN Presswire
·
July 22, 2025
A randomized controlled trial shows that therapists using the AI assistant spent 55% less time on documentation and reported better therapy outcomes. MIAMI, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- A growing body of research shows that …
Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide
GlobeNewswire
·
July 22, 2025
MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including …
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
GlobeNewswire
·
July 22, 2025
VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
GlobeNewswire
·
July 22, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
GlobeNewswire
·
July 22, 2025
Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …
DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines
GlobeNewswire
·
July 22, 2025
Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …
STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025
GlobeNewswire
·
July 22, 2025
DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference …
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 22, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August …
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
GlobeNewswire
·
July 22, 2025
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 50 mg once-daily dose of obefazimod led to a …
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on …
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
GlobeNewswire
·
July 22, 2025
WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 22, 2025
CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Sanuwave Health to Present at Canaccord Genuity Growth Conference
GlobeNewswire
·
July 22, 2025
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th …